Ticker Details
Gossamer Bio, Inc.
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$87.21M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.66%
Avg Daily Range (30 D):	$0.03 | 6.47%
Avg Daily Range (90 D):	$0.08 | 5.16%

Institutional Daily Volume
Avg Daily Volume:	1.76M
Avg Daily Volume (30 D):	12.26M
Avg Daily Volume (90 D):	10.97M

Trade Size
Avg Trade Size (Sh.):	232
Avg Trade Size (Sh.) (30 D):	529
Avg Trade Size (Sh.) (90 D):	452

Institutional Trades
Total Institutional Trades:	1,350
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$2.27M
Avg Institutional Trade (90 D):	$1.44M
Avg Institutional Trade Volume:	.29M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.7M
Avg Closing Trade (30 D):	$3.37M
Avg Closing Trade (90 D):	$1.68M
Avg Closing Volume:	355.76K

News

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Apr 6, 2026 @ 9:49 PM Holzer & Holzer, LLC Reminds Investors of June 1, ... Source: Holzer & Holzer, Llc

Apr 1, 2026 @ 4:46 PM Gainey McKenna & Egleston Announces A Class Action... Source: Gainey Mckenna & Egleston

Mar 18, 2026 @ 10:00 AM XOMA Royalty Reports 2025 Financial Results and Hi... Source: Na

Mar 10, 2026 @ 8:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.69	$-.21	$-.17
Diluted EPS	$-.69	$-.21	$-.17
Revenue	$44.05M	$13.29M	$11.49M
Gross Profit
Net Income / Loss	$-156.16M	$-48.22M	$-38.27M
Operating Income / Loss	$-160.82M	$-49.11M	$-38.77M
Cost of Revenue
Net Cash Flow	$-19.55M	$-17.28M	$-2.84M
PE Ratio